TOP STORY: NEA Leads Syndicate Investing $25M in Series A Funds
to Launch New Biotech, VTESSE, INC., in Gaithersburg
|
Vtesse, Inc., a rare disease company focused on developing drugs for Niemann-Pick Disease Type C and other severe diseases, announced today that it has raised $25 million in Series A funding and established its headquarters office in Gaithersburg, MD.
|